| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NAKAKindly MD, Inc. | 325.71M | 0.48 | -0.72 | -27.83% | -45.7% | -18.95% | 0.31 |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Sales/Revenue | 2.5M | 3.79M | 3.77M | 2.72M |
| Revenue Growth % | - | 0.51% | -0% | -0.28% |
| Cost of Goods Sold | 1.59M | 4.38M | 4.03M | 82.81K |
| COGS % of Revenue | 0.63% | 1.16% | 1.07% | 0.03% |
| Gross Profit | 914.92K | -595.29K | -264.17K | 2.64M |
| Gross Margin % | 0.37% | -0.16% | -0.07% | 0.97% |
| Gross Profit Growth % | - | -1.65% | 0.56% | 10.98% |
| Operating Expenses | 853.58K | 2.1M | 1.36M | 5.98M |
| OpEx % of Revenue | 0.34% | 0.55% | 0.36% | 2.2% |
| Selling, General & Admin | 853.58K | 2.1M | 1.36M | 5.47M |
| SG&A % of Revenue | 0.34% | 0.55% | 0.36% | 2.01% |
| Research & Development | 0 | 0 | 0 | 377.73K |
| R&D % of Revenue | - | - | - | 0.14% |
| Other Operating Expenses | 0 | 0 | 0 | 136.61K |
| Operating Income | 61.34K | -2.69M | -1.62M | -3.35M |
| Operating Margin % | 0.02% | -0.71% | -0.43% | -1.23% |
| Operating Income Growth % | - | -44.91% | 0.4% | -1.07% |
| EBITDA | 124.74K | -2.57M | -1.42M | -3.13M |
| EBITDA Margin % | 0.05% | -0.68% | -0.38% | -1.15% |
| EBITDA Growth % | - | -21.61% | 0.45% | -1.21% |
| D&A (Non-Cash Add-back) | 63.4K | 122K | 203.22K | 220.33K |
| EBIT | 61.34K | -2.54M | -1.56M | -3.22M |
| Net Interest Income | 0 | 0 | -55.84K | -393.45K |
| Interest Income | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 55.84K | 393.45K |
| Other Income/Expense | 88K | 152.82K | 2.76K | -270.88K |
| Pretax Income | 149.34K | -2.54M | -1.62M | -3.62M |
| Pretax Margin % | 0.06% | -0.67% | -0.43% | -1.33% |
| Income Tax | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% |
| Net Income | 149.34K | -2.54M | -1.62M | -3.62M |
| Net Margin % | 0.06% | -0.67% | -0.43% | -1.33% |
| Net Income Growth % | - | -18.01% | 0.36% | -1.24% |
| Net Income (Continuing) | 149.34K | -2.54M | -1.62M | -3.62M |
| Discontinued Operations | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.03 | -0.43 | -0.27 | -0.67 |
| EPS Growth % | - | -18.13% | 0.37% | -1.48% |
| EPS (Basic) | 0.03 | -0.43 | -0.27 | -0.67 |
| Diluted Shares Outstanding | 5.94M | 5.89M | 5.89M | 5.39M |
| Basic Shares Outstanding | 5.89M | 5.89M | 5.89M | 5.39M |
| Dividend Payout Ratio | - | - | - | - |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Total Current Assets | 269.44K | 309.57K | 616.93K | 2.51M |
| Cash & Short-Term Investments | 94.69K | 186.92K | 525.5K | 2.27M |
| Cash Only | 94.69K | 186.92K | 525.5K | 2.27M |
| Short-Term Investments | 0 | 0 | 0 | 0 |
| Accounts Receivable | 13.47K | 12.12K | 28K | 36.85K |
| Days Sales Outstanding | 1.96 | 1.17 | 2.71 | 4.95 |
| Inventory | 59.77K | 49.57K | 63.2K | 4.3K |
| Days Inventory Outstanding | 13.73 | 4.13 | 5.72 | 18.95 |
| Other Current Assets | 66.21K | 60.96K | 226 | 190.88K |
| Total Non-Current Assets | 178.2K | 637.43K | 482.27K | 1.17M |
| Property, Plant & Equipment | 171.57K | 622.93K | 471K | 764.61K |
| Fixed Asset Turnover | 14.60x | 6.08x | 8.00x | 3.56x |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 388.34K |
| Long-Term Investments | 6.63K | 14.51K | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 11.28K | 19.4K |
| Total Assets | 447.64K | 947K | 1.1M | 3.68M |
| Asset Turnover | 5.59x | 4.00x | 3.43x | 0.74x |
| Asset Growth % | - | 1.12% | 0.16% | 2.35% |
| Total Current Liabilities | 118.29K | 327.9K | 814.45K | 606.05K |
| Accounts Payable | 47.5K | 166.26K | 329.81K | 323.73K |
| Days Payables Outstanding | 10.91 | 13.85 | 29.85 | 1.43K |
| Short-Term Debt | 53.54K | 92.55K | 148.52K | 139.28K |
| Deferred Revenue (Current) | 17.25K | 8.6K | 3.42K | 2.27K |
| Other Current Liabilities | 0 | 0 | 238K | 0 |
| Current Ratio | 2.28x | 0.94x | 0.76x | 4.13x |
| Quick Ratio | 1.77x | 0.79x | 0.68x | 4.13x |
| Cash Conversion Cycle | 4.78 | -8.55 | -21.42 | -1.4K |
| Total Non-Current Liabilities | 56.27K | 238.09K | 393.17K | 503.63K |
| Long-Term Debt | 0 | 0 | 228.87K | 0 |
| Capital Lease Obligations | 56.27K | 238.09K | 164.29K | 503.63K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | 174.56K | 565.98K | 1.21M | 1.11M |
| Total Debt | 109.81K | 391.13K | 636.38K | 783.68K |
| Net Debt | 15.12K | 204.21K | 110.88K | -1.49M |
| Debt / Equity | 0.40x | 1.03x | - | 0.31x |
| Debt / EBITDA | 0.88x | - | - | - |
| Net Debt / EBITDA | 0.12x | - | - | - |
| Interest Coverage | - | - | -29.01x | -8.51x |
| Total Equity | 273.09K | 381.01K | -108.41K | 2.57M |
| Equity Growth % | - | 0.4% | -1.28% | 24.69% |
| Book Value per Share | 0.05 | 0.06 | -0.02 | 0.48 |
| Total Shareholders' Equity | 273.09K | 381.01K | -108.41K | 2.57M |
| Common Stock | 273.09K | 4.43K | 4.62K | 6.05K |
| Retained Earnings | 0 | -2.54M | -4.16M | -7.78M |
| Treasury Stock | 0 | 0 | 0 | -22.14K |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 |
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Cash from Operations | 121.44K | -140.38K | -449.49K | -3.07M |
| Operating CF Margin % | 0.05% | -0.04% | -0.12% | -1.13% |
| Operating CF Growth % | - | -2.16% | -2.2% | -5.84% |
| Net Income | 149.34K | -2.54M | -1.62M | -3.62M |
| Depreciation & Amortization | 63.4K | 122K | 203.22K | 220.33K |
| Stock-Based Compensation | 0 | 2.22M | 414.69K | 161.29K |
| Deferred Taxes | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 28.63K | 433.7K | 464.1K |
| Working Capital Changes | -91.29K | 33.23K | 116.36K | -301.97K |
| Change in Receivables | 401 | -7.12K | -15.88K | -40.96K |
| Change in Inventory | -30.64K | 10.2K | -13.63K | 58.9K |
| Change in Payables | 0 | 122.31K | 163.55K | -6.08K |
| Cash from Investing | -63.6K | -317.39K | -14.42K | -401.63K |
| Capital Expenditures | -63.6K | -317.39K | -14.42K | -13.29K |
| CapEx % of Revenue | 0.03% | 0.08% | 0% | 0% |
| Acquisitions | - | - | - | - |
| Investments | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -388.34K |
| Cash from Financing | -45.34K | 550K | 802.49K | 5.22M |
| Debt Issued (Net) | - | - | - | - |
| Equity Issued (Net) | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - |
| Other Financing | 0 | 0 | 0 | 0 |
| Net Change in Cash | - | - | - | - |
| Free Cash Flow | 57.84K | -457.77K | -463.91K | -3.48M |
| FCF Margin % | 0.02% | -0.12% | -0.12% | -1.28% |
| FCF Growth % | - | -8.91% | -0.01% | -6.49% |
| FCF per Share | 0.01 | -0.08 | -0.08 | -0.64 |
| FCF Conversion (FCF/Net Income) | 0.81x | 0.06x | 0.28x | 0.85x |
| Interest Paid | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 |
| Metric | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Return on Equity (ROE) | 54.68% | -776.82% | -1186.68% | -294.13% |
| Return on Invested Capital (ROIC) | - | -462.56% | -413.54% | -464.47% |
| Gross Margin | 36.53% | -15.72% | -7.01% | 96.96% |
| Net Margin | 5.96% | -67.09% | -42.92% | -133.01% |
| Debt / Equity | 0.40x | 1.03x | - | 0.31x |
| Interest Coverage | - | - | -29.01x | -8.51x |
| FCF Conversion | 0.81x | 0.06x | 0.28x | 0.85x |
| Revenue Growth | - | 51.22% | -0.49% | -27.83% |
| 2024 | |
|---|---|
| Product Retail Sales | 71.71K |
| Product Retail Sales Growth | - |
Kindly MD, Inc. (NAKA) reported $2.0M in revenue for fiscal year 2024. This represents a 21% decrease from $2.5M in 2021.
Kindly MD, Inc. (NAKA) saw revenue decline by 27.8% over the past year.
Kindly MD, Inc. (NAKA) reported a net loss of $90.5M for fiscal year 2024.
Kindly MD, Inc. (NAKA) has a return on equity (ROE) of -294.1%. Negative ROE indicates the company is unprofitable.
Kindly MD, Inc. (NAKA) had negative free cash flow of $19.8M in fiscal year 2024, likely due to heavy capital investments.